Hepatitis Vaccination and Prophylaxis

Clinics in Liver Disease

Volumn 13, Issue 2, 2009, Pages 317-329

  Nguyen, Carolyn T ^a   Tran, Tram T ^b  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Hepatitis A; Hepatitis B; Hepatitis C; Prophylaxis; Vaccinations; Viral hepatitis

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; HAEMOPHILUS INFLUENZAE TYPE B HEPATITIS B VACCINE; HEPATITIS A HEPATITIS B VACCINE; HEPATITIS A VACCINE; HEPATITIS B ANTIBODY; HEPATITIS B VACCINE; HEPATITIS C VACCINE; HEPATITIS VACCINE; IMMUNOGLOBULIN; RECOMBINANT HEPATITIS B VACCINE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANUS INTERCOURSE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD CLOTTING FACTOR DEFICIENCY; CATERING SERVICE; CHILD CARE; CHRONIC LIVER DISEASE; DEVELOPMENTAL DISORDER; DONOR; HEALTH CARE; HEMODIALYSIS PATIENT; HEPATITIS; HEPATITIS A; HEPATITIS A VIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HIGH RISK POPULATION; IMMUNOCOMPROMISED PATIENT; INFECTION PREVENTION; INFECTION RATE; INFECTION RISK; INFLUENZA; MALE HOMOSEXUAL; NONHUMAN; OCCUPATIONAL EXPOSURE; PRACTICE GUIDELINE; PREGNANT WOMAN; PRIMATE; REVIEW; SCHOOL; SINGLE DRUG DOSE; TRAVEL; TREATMENT INDICATION; VACCINATION;

ADULT; HEPATITIS A; HEPATITIS A VACCINES; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION, PASSIVE; IMMUNOGLOBULINS; INFANT; VACCINATION;

EID: 65149089760     PISSN: 10893261     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cld.2009.02.005     Document Type: Review

References (19)

1. Centers for Disease Control and Prevention. Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. MMWR Recomm Rep 57 RR-8 (2008) 1-20
2. Previsani N., and Lavanchy D. Hepatitis A (2000), Switzerland: World Health Organization p. 1-41
3. Wasley A., Fiore A., and Pell B. Hepatitis A in the era of vaccination. Epidemiol Rev 28 (2006) 101-111
4. Vogt T., Wise M., Pell B., et al. Declining hepatitis A mortality in the United States during the era of hepatitis A vaccination. J Infect Dis 197 (2008) 1282-1288
5. Worns M., Teufel A., Kanzler A., et al. Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases. Am J Gastroenterol 103 1 (2008) 138-146
6. Reiss G., and Keeffe E. Review article: hepatitis vaccination in patients with chronic liver disease. Aliment Pharmacol Ther 19 (2004) 715-727
7. Vento S., Garofano T., Renzini C., et al. Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C. N Engl J Med 338 5 (1998) 286-290
8. Centers for Disease Control and Prevention. Prevention of hepatitis A through active or passive immunizations. MMWR Recomm Rep 45 RR-15 (1996) 1-23
9. Centers for Disease Control and Prevention. Update: prevention of hepatitis A after exposure to hepatitis A virus and in international travelers. Updated recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep 56 41 (2007) 1080-1084
10. Fiore A.E., Wasley A., Bell B.P., and for the Advisory Committee on Immunization Practices (ACIP). Prevention of hepatitis A through active or passive immunization. MMWR Recomm Rep 55 RR-07 (2006) 1-23
11. Alter M. Epidemiology of viral hepatitis and HIV co-infection. J Hepatol 44 (2006) S6-S9
12. Shepard C.W., Simard E.P., Finelli L., et al. Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev 28 (2006) 112-125
13. Cardell K., Akerlind B., Sallberg M., et al. Excellent response rate to a double dose of the combined hepatitis A and B vaccine in previous nonresponders to hepatitis B vaccine. J Infect Dis 198 (2008) 299-304
14. Centers for Disease Control and Prevention. Surveillance for acute viral hepatitis - United States, 2006. MMWR Recomm Rep 57 SS-2 (2008) 1-24
15. Centers for Disease Control and Prevention. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the advisory committee on immunization practices (ACIP): part I: immunization of infants, children, and adolescents. MMWR Recomm Rep 54 RR-16 (2005) 1-30
16. Centers for Disease Control and Prevention. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendation of the advisory committee on immunization practices (ACIP) part II: immunization of adults. MMWR Recomm Rep 55 RR-16 (2006) 1-23
17. Centers for Disease Control and Prevention. Recommendations for preventing transmission of infections among chronic hemodialysis patients. MMWR Recomm Rep 50 RR-5 (2001) 1-43
18. Keck Z.Y., Olson O., Gal-Tanamy M., et al. A point mutation leading to hepatitis C virus escape from neutralization by a monoclonal antibody to a conserved conformational epitope. J Virol 82 (2008) 6067-6072
19. Perotti M., Mancini N., Diotti R., et al. Identification of a broadly cross-reacting and neutralizing human monoclonal antibody directed against the hepatitis C virus e2 protein. J Virol 82 (2008) 1047-1052